Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN108383880A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108383880A reveals novel coumarin-platinum complexes targeting ovarian cancer resistance. Offers high purity and scalable synthesis for pharmaceutical supply chains.